Montpellier University Hospital leads a 43-center French effort that reports no reduction in day 90 all-cause mortality with ...
Sodium bicarbonate has emerged as a notable ergogenic aid in sports science, primarily due to its ability to augment extracellular buffering capacity and mitigate the accumulation of metabolic acids ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch1 of 8.4% Sodium Bicarbonate ...
Glenmark Pharmaceuticals is set to introduce a generic medication in the US to treat high acid levels. The product, ...
RANCHO CUCAMONGA, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (“FDA”) granted approval of its ...
Glenmark Pharma to launch generic Sodium Bicarbonate Injection in the US for treating metabolic acidosis. Distribution starts ...
The injection, available in a 50 mEq/50 mL (1 mEq/mL) single-dose vial, is bioequivalent and therapeutically equivalent to ...
Capital Market on MSN
Glenmark Pharmas US subsidiary to launch 8.4% sodium bicarbonate injection in US market
The product has been deemed bioequivalent and therapeutically equivalent to the reference listed drug, 8.4% Sodium ...
More than 1,321 recalls were issued last year for human drug products that were defective or violated laws enforced by the U.S. Food and Drug Administration. It’s the highest figure in the past three ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback